Zosano Pharma Corp

NASDAQ:ZSAN  
0.94
+0.01 (+0.83%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)65.04M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.17 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$0.88
50-Day MA$0.91
200-Day MA$0.97
See more pivots

Zosano Pharma Corp Stock, NASDAQ:ZSAN

34790 Ardentech Court, Fremont, California 94555
United States of America
Phone: +1.510.745.1200
Number of Employees: 45

Description

Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. The firm focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. It offers Qtrypta, a formulation of zolmitriptan delivered utilizing the intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA.